Yang Liu
Impact in
- Cancer Research top 0.05%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 0.1%
- RNA modifications and cancer
- Circular RNAs in diseases
- Extracellular vesicles in disease
- RNA Research and Splicing
Papers in
-
- RNA modifications and cancer 105
- Circular RNAs in diseases 78
- Surgery 323
- Co-authors
- Hua Li (4 shared papers)Lixia Chen (4 shared papers)Peng Zhang (5 shared papers)Mengzhu Zheng (2 shared papers)Yueying Yang (2 shared papers)Canrong Wu (2 shared papers)Xingzhou Li (1 shared paper)Yang Xu (1 shared paper)
- Journals
- Scientific Reports (26 papers)Medicine (21 papers)Frontiers in Oncology (20 papers)Frontiers in Immunology (20 papers)PLoS ONE (19 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Yang Liu
1.8k papers receiving 33.4k citations
Yang Liu's Hit Papers
Peers
Comparison fields: 5 of 212
- Cancer Research 6.9k
- Molecular Biology 13.8k
- Immunology 3.2k
- Oncology 3.2k
- Pharmacology 1.8k
Countries citing papers authored by Yang Liu
This map shows the geographic impact of Yang Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Liu more than expected).
Fields of papers citing papers by Yang Liu
This network shows the impact of papers produced by Yang Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Liu. The network helps show where Yang Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yang Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 1.9k papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods Hit paper breakdown → | 2020 | 1653 |
| 2 | Mapping global prevalence of depression among postpartum women Hit paper breakdown → | 2021 | 370 |
| 3 | 2002 | 365 | |
| 4 | 2014 | 346 | |
| 5 | Engineered exosomes from different sources for cancer-targeted therapy Hit paper breakdown → | 2023 | 292 |
| 6 | Evolutionary enhancement of Zika virus infectivity in Aedes aegypti mosquitoes Hit paper breakdown → | 2017 | 281 |
| 7 | 2009 | 251 | |
| 8 | 2012 | 232 | |
| 9 | 2012 | 212 | |
| 10 | 2020 | 203 | |
| 11 | 2010 | 201 | |
| 12 | Cuproptosis-Related Risk Score Predicts Prognosis and Characterizes the Tumor Microenvironment in Hepatocellular Carcinoma Hit paper breakdown → | 2022 | 192 |
| 13 | 2013 | 188 | |
| 14 | 2015 | 176 | |
| 15 | 2012 | 168 | |
| 16 | 2014 | 164 | |
| 17 | 2018 | 162 | |
| 18 | RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential Hit paper breakdown → | 2022 | 159 |
| 19 | 2016 | 155 | |
| 20 | 2011 | 153 |
About Yang Liu
Yang Liu is a scholar working on Molecular Biology, Surgery, Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 1.9k papers that have together received 33.9k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (126 papers), RNA modifications and cancer (105 papers), MicroRNA in disease regulation (104 papers), Circular RNAs in diseases (78 papers), Ferroptosis and cancer prognosis (55 papers), Microbial Natural Products and Biosynthesis (50 papers), Corneal Surgery and Treatments (49 papers) and Ocular Surface and Contact Lens (42 papers). The work is most often cited by research in Cancer Research (6.9k citations), Molecular Biology (13.8k citations), Immunology (3.2k citations), Oncology (3.2k citations) and Pharmacology (1.8k citations). Yang Liu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Hua Li, Lixia Chen, Peng Zhang, Mengzhu Zheng, Yueying Yang, Canrong Wu, Xingzhou Li, Yang Xu, Yali Wang and Wu Zhong. Their work appears in journals such as Scientific Reports, Medicine, Frontiers in Oncology, Frontiers in Immunology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.